Ranbaxy Pharmaceuticals (RPI) is in a real no-name business. The company, the US arm of Indian generic pharmaceuticals giant Ranbaxy Laboratories Limited, makes and markets dozens of generic and over-the-counter (OTC) drugs. RPI's generic offerings, produced by manufacturing subsidiary Ohm Laboratories, include anti-infectives and treatments for cardiovascular, gastrointestinal, and central nervous system disorders. Its OTC products include analgesics, antihistamines, and decongestants. Sister subsidiary Ranbaxy Laboratories, Inc. (RLI) develops branded pharmaceuticals.